NHS Blood and Transplant (NHSBT) Blood Donor Centre, John Radcliffe Hospital, Oxford, OX3 9BQ
Senior Research Associate
- CEO of the Centre of Evidence for Transplantation
I started working as a research associate for the Centre for Evidence in Transplantation in January 2005.
I have been involved in the evaluation of the methodological quality of recently published randomised controlled trials (RCTs) in solid organ transplantation. These quality scores were first published as a regular Special Feature in the journal Transplantation and are now included in the Transplant Library. The Transplant Library has been developed by the CET and includes all randomised controlled trials and selected, good quality systematic reviews in solid organ transplantation. It was designed to provide easy and quick access to high quality evidence based information on all aspects of organ transplantation.
I have recently completed a systematic review on the incidence of wound complications and lymphoceles in solid organ transplant recipients on mTOR inhibitors and a review of the compliance of RCT reports to the CONSORT statement over a three-year period. I am currently working on a project investigating the rate of publication of abstracts presented at scientific meetings.
I am the main link in the collaboration between the European Society of Organ Transplantation (ESOT) and the CET. The aim of the collaboration is to improve the quality of clinical research in solid organ transplantation in Europe. As part of the collaboration we provide help with designing and reporting randomised controlled trials to European transplant professionals. Each year we also run the Evidence in Transplantation (EVIT) course which is aimed at transplant professionals who want to increase their evidence-based decision making skills.
Alloimmune Risk Stratification for Kidney Transplant Rejection
Bestard O. et al, (2022), Transplant International, 35
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
Roufosse C. et al, (2022), Transplant International, 35
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
Seron D. et al, (2022), Transplant International, 35
The risks for donors associated with living kidney donation: systematic review
PENGEL L., (2022), British Journal of Surgery
Patient-reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
PENGEL L., (2022), Transplant International